Stocks Health care AWHL
OTC · Health careAspira Women's Health Inc. (AWHL)
Aspira Women's Health Inc. brought in $8.5M of revenue over the twelve months to June 30, 2026, down 8.0% from a year earlier. It posted a net loss of $10M. In fiscal 2025 capital spending exceeded operating cash flow by $7M. At June 30, 2026 it held $477K in cash against $1.2M of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 14, 2026.
Watch AWHL in 60 secondsWhat Aspira Women's Health Inc. does
Aspira Women's Health Inc. is registered with the SEC under industry code SIC 2835 (In Vitro & In Vivo Diagnostic Substances). Its shares trade on OTC under the ticker AWHL.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $9.2M | -$12.8M | -$0.37 | -$7M |
| 2024 | $9.2M | -$13.1M | -$0.93 | -$12.2M |
| 2023 | $87M | -$16.7M | -$1.81 | -$15.9M |
| 2022 | $8.2M | -$29.9M | -$3.85 | -$31.3M |
| 2021 | $6.8M | -$31.7M | -$4.27 | -$27.6M |
| 2020 | $4.7M | -$17.9M | -$2.75 | -$15.2M |
Full financial statements: income, balance sheet and cash flow
Where AWHL ranks in Health care
Latest SEC filings
What Aspira Women's Health Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- August 14, 2026Quarterly report 10-Q · period to June 30, 2026Revenue fell 15% to $2M versus the same quarter last year; diluted EPS -$0.05 versus -$0.07.
- July 15, 2026
- July 7, 2026
- June 22, 2026
- June 17, 2026
- June 11, 2026Activist stake changed SCHEDULE 13D/A
- June 9, 2026
- May 29, 2026Additional proxy material DEFA14A
- May 26, 2026
- May 15, 2026Quarterly report 10-Q · period to March 31, 2026Revenue fell 14% to $2M versus the same quarter last year; diluted EPS -$0.05 versus -$0.09.
Insider trades
What the people running Aspira Women's Health Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.
No insider trades were reported in the last 90 days.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| June 5, 2026 | Schuler Jack W10% owner | Boughtindirect | 222,222 | $100K |
Who owns AWHL
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| Schuler Jack W13D, may seek influence with 1 related filers | 8.7% | June 11, 2026 |
Largest institutional holders
Insiders
3 insiders reported holding 4,998,462 shares in total, about $1.3M at the last price.
| Holder | Shares |
|---|---|
| Schuler Jack W10% owner | 4,046,0514,046,051 held indirectly |
| Fraser John DDirector | 566,393 |
| cohen Jeffrey kDirector | 386,018 |
Questions about AWHL
What does Aspira Women's Health Inc. do?
Aspira Women's Health Inc. is registered with the SEC under industry code SIC 2835 (In Vitro & In Vivo Diagnostic Substances). Its shares trade on OTC under the ticker AWHL.
Is Aspira Women's Health Inc. profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $10M on revenue of $8.5M.
How much revenue does Aspira Women's Health Inc. make?
Over the twelve months to June 30, 2026 Aspira Women's Health Inc. reported revenue of $8.5M. That is 8.0% less than a year earlier.
When did Aspira Women's Health Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 14, 2026. It covers the period to June 30, 2026.
Similar companies
Compare AWHL with
Follow AWHL
Get an email when Aspira Women's Health Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Follow AWHL: get an email when it filesWhere the numbers come from
Financial figures are the values Aspira Women's Health Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.